Versuchen GOLD - Frei
RISING STOCK
THE WEEK India
|April 14, 2024
Recent initiatives by SEBI have made capital markets a better place for investors
January 27, 2023, was a significant day in the history of India's capital markets-they fully transitioned to T+1 settlements, which meant if you sold shares you would get the money in your account the next day.
They went one better on March 25, 2024, as the stock exchanges debuted T+0 settlement for 25 scrips, which meant sellers would get their money on the same day. The plan is to move to instantaneous settlements next year.
The journey towards shorter settlement had begun when the Securities and Exchange Board of India allowed exchanges to move from T+2 to T+1 settlement cycle in January 2022. It was done in phases and took a year for complete switching. There were hiccups. The custodians of foreign institutional investors resisted it citing some difficulties. But, SEBI chairperson Madhabi Puri Buch ensured that all of them were ironed out.
Quicker settlements offer many benefits, notably the reduction of counterparty risk (the probability that the other party may not fulfil the contractual obligations) and the bolstering of market efficiency, said Rakeshh Mehta, chairman of Mehta Equities. "Furthermore, it is anticipated to substantially lower operational expenses for market participants and reduce the funding costs that brokers face," he said.
There are, however, many challenges and concerns. A shorter settlement cycle would necessitate an overhaul of the market infrastructure, systems and processes. Also, it may contribute to an increase in market volatility. SEBI says it will continue consultations with stakeholders and the board will review the progress periodically.
Diese Geschichte stammt aus der April 14, 2024-Ausgabe von THE WEEK India.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON THE WEEK India
THE WEEK India
Fire, smoke and soaring worries
The PSLV C-62 fiasco is a stress test of ISRO's technical systems, organisational processes and market credibility
7 mins
January 25, 2026
THE WEEK India
The dinosaur and the dictator
Dictators have a few things in common with T. rex, the king of dinosaurs. Both dominate their sphere of influence through brute force.
2 mins
January 25, 2026
THE WEEK India
We are developing master plans for tourism destinations
Across the world, the tourism development is more about providing seamless connection and basic infra like transportation, lodging and boarding.
2 mins
January 25, 2026
THE WEEK India
A TIGHTROPE WALK
As small-caps are yet to find valuation comfort, 2026 would be a challenging year for them
4 mins
January 25, 2026
THE WEEK India
ON THIN ICE
With the intensification of great-power rivalries in the region, Greenland's strategic and resource potential has become salient
5 mins
January 25, 2026
THE WEEK India
Elgin, Ephesus and Erdogan
Lord Elgin was wrong. Not the eighth earl whom we know as a viceroy of India, but his more famous father, the seventh who had carted away the Parthenon Marbles from Athens during 1802-1812. Elgin feared the Ottoman Turks, who had occupied Greece, might vandalise them.
2 mins
January 25, 2026
THE WEEK India
Art at the heart
The sixth edition of the Kochi-Muziris Biennale reclaims its legacy
6 mins
January 25, 2026
THE WEEK India
BENIGN PROSTATIC HYPERPLASIA (BPH): Understanding Symptoms, Diagnosis & Modern Treatment Options
Benign Prostatic Hyperplasia (BPH) is a very common medical condition affecting aging men, particularly those above 50 years.
2 mins
January 25, 2026
THE WEEK India
ERA OF THE NEW NORMAL
The confrontations with China and Pakistan have added another dimension to the ever-evolving nature of the Indian military
5 mins
January 25, 2026
THE WEEK India
Affordable CAR-T Therapy Brings New Hope for Blood Cancer Patients in India
For thousands of Indians battling blood cancers, a once-unimaginable dream is fast becoming reality. Cutting-edge CART cell therapy a breakthrough treatment that uses a patient's own immune system to fight cancer is now available in India at a fraction of global costs, offering renewed hope to patients with advanced disease.
1 mins
January 25, 2026
Listen
Translate
Change font size

